Answers are grounded in this paper and cite their sources.
I read the article by Garrett et al., “Novel Drug OMS103HP Reduces Pain and Improves Joint Motion for 90 days After Arthroscopic Menisectomy,”1 and also your commentary in the editorial section in the August issue. You state that “no study is perfect, and the cited randomized controlled trial does have limitations.” There is further mention of the financial disclosures in the article.
No takes yet. Share an insight, caveat, or question.
Mark G. Siegel (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: